BioFluidica to Introduce Next-Generation Biomarker Isolation Platform

Hitesh
thehealthco

Biofluidica, Inc., a privately held biotechnology company, today announced they will be introducing their new biomarker isolation platform, LiquidScan™, at the annual AACR Conference on April 10-13 in New Orleans. The novel platform isolates and enhances biomarker population directly from a blood draw replacing the need for surgical biopsies and making available potential tests for tissues not available for biopsy.

Read More

Next Post

Shionogi Partners with Cloudera to Accelerate R&D and Achieve Data-Driven Innovation in Pharmaceuticals

Cloudera, the hybrid data cloud company, today announced that Japanese pharmaceutical company, Shionogi & Co., Ltd., has selected Cloudera to boost its data analytics capabilities for increased business performance and realize its vision of achieving data-driven innovation. Through this partnership, Shionogi hopes to democratize access to its vast amounts of […]
thehealthco